Skip to content

Our Strategy

As a non-profit association which brings together industry and academic stakeholders, the PRI employs a collaborative approach to developing and sharing Regulatory Science expertise for the development of microbiome-based medicinal products. 

Regulatory Science Center

The PRI is Europe’s first microbiome regulatory science expertise center and was founded in 2010 to support the development of microbiome-based medicinal products for the EU market, for human and veterinary applications.

Mission

We strive to identify and confirm the specific scientific and technical requirements for the development of microbiome-based medicinal products for the EU market. We do this through a collaborative ‘Share & Learn’ approach.

Objective

It is the PRI’s ultimate ambition to ensure that safe and efficacious microbiome-based medicinal products of appropriate quality reach European patients, many of whom suffer from unmet medical needs.

Partnering Membership

Active Support

Active Support

Active support in identifying potential partnerships

Annual Event

Annual Event

Invitation to annual exclusive Member Event for Partnering + Innovation Showcase

Task Groups

Task Groups

PRI Task Groups* (Non-regulatory topics only) 

Digital Promotion

Digital Promotion

Promotion on PRI website (logo, blog articles, newsletters) & social media (LinkedIn, Twitter)

Discounted Rates

Discounted Rates

Discounted Rate (up to 20%) to attend + advantages for sponsoring at the annual Pharmabiotics Conference & Partnering event

Regulatory Membership

*Includes all advantages of Partnering Membership

On-site Workshops

On-site Workshops

Customized on-site workshops with our regulatory affairs experts to de-risk and accelerate your product development

Unique Expertise

Unique Expertise

PRI internal guidelines & previous scientific advice intelligence

Task Groups

Task Groups

All PRI Task Groups (regulatory & technical). These ad-hoc working groups focus on the most pressing questions facing the industry – eg. ‘Clinical Studies’, ‘Analytics’, ‘Safety’, ‘Inactivated Cells’…

Future Outlook

Future Outlook

Foresight of future regulatory challenges

Regulatory Strategy

Regulatory Strategy

PRI regulatory strategy (EMA Scientific Advice Request dossier results) – the ‘overview effect’

Keeping Up

Keeping Up

Current European regulatory intelligence updates Eg. European Pharmacopeia or CAMD Medical Device Status

Valuable Insight

Valuable Insight

Actively provide you with a unique understanding of the authorities’ mindset/approach to microbiome-based products (LBPs/MMPs)

Fee Structure

Scroll to view our Regulatory Membership Fees Structure

Membership Fees Structure

Regulatory Membership

(Tech Transfer-TTO Projects, Biotechs and Commercial groups)

Incubator & Partnering Membership

(Microbiome Accelerators/ Incubators, Service Providers & Academic groups)

Organization

Organization 

Membership Dues (annual)

Membership Dues (annual)

Tech. Transfer Project

Biotech (not-yet-in-profit)

Commercial (profitable)

€ 4 000

€ 6 000

€ 10 000

Incubator Member

Partnering Member

Associate Member (Research/Academia)

€ 1 500

€ 1 500

€ 0

Membership Fees Structure

Regulatory Membership

(Tech Transfer-TTO Projects, Biotechs and Commercial Groups)

Organization

Membership Dues (annual)

Tech. Transfer Project

Biotech (not-yet-in-profit)

Commercial (profitable)

€ 4 000

€ 6 000

€ 10 000

Partnering Membership

(Microbiome Accelerators/Incubators, Service Providers & Academic groups)

Organization

Membership Dues (annual)

Incubator Member 

Partnering Member 

Associate Member 

€ 1 500

€ 1 500

No Charge